Nutritional status and incidence of hepatocellular carcinoma in patients with compensated liver cirrhosis

被引:0
作者
Lopez-Sanchez, Marlene [1 ]
Bautista-Santos, Aleida [2 ]
Milke-Garcia, Maria del Pilar [3 ]
Allende-Lopez, Aldo [1 ]
Moreno-Alcantar, Rosalba [2 ]
Moran, Segundo [1 ]
机构
[1] Ctr Med Nacl Siglo XXI, Inst Mexicano Seguro Social, Lab Hepatol Res, Mexico City, Mexico
[2] Ctr Med Nacl Siglo XXI, Gastroenterol Serv, Inst Mexicano Seguro Social, Mexico City, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Hematooncol Dept, Mexico City, Mexico
关键词
Hepatocellular carcinoma; Nutritional assessment; Compensated liver cirrhosis; NATURAL-HISTORY; HEPATITIS-C; RISK-FACTORS; MALNUTRITION; AMINOTRANSFERASE; PROGRESSION; MORTALITY; ALPHA;
D O I
10.1016/j.arcmed.2024.103127
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Malnutrition in patients with liver cirrhosis (LC) and/or hepatocellular carcinoma (HCC) has been associated with adverse outcomes. However, there is little information on the incidence of HCC during the compensated phase of LC in relation to the nutritional status. Aim. To evaluate the association between the incidence of HCC in compensated LC and their nutritional status. Methods. Patients with compensated liver cirrhosis with no previous history of ascites, hepatic encephalopathy, or variceal bleeding attending the Gastroenterology outpatient service at Centro Medico Nacional Siglo XXI were included in a prospective cohort. Clinical and nutritional parameters were collected, including the Royal Free Hospital Subjective Global Assessment (RFH-SGA) as an indicator of protein-calorie malnutrition and the triceps skinfold thickness, which classified patients as having normal subcutaneous adipose tissue (SAT), above average SAT, and below average SAT. Follow-up was censored at the time of HCC diagnosis or LC decompensation. Results. About 31/187 (16.0 %) and 22/187 (11.8 %) patients were categorized as having above- or below-average SAT at baseline, respectively. 10/187 patients (5.3 %) developed HCC during the compensated phase of LC at a median of 22 months (IQR: 10.0-36.75). A higher risk of HCC was observed in subjects below average SAT (HR: 4.064, CI 95 %: 1.012-16.317, p = 0.048). After adjusting the Cox models for age and alpha-fetoprotein at baseline, the statistical significance of the association between SAT and HCC was not modified. Conclusion. These results suggest that decreased SAT may precede the diagnosis of HCC by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:14
相关论文
共 47 条
[1]   Natural history of compensated viral cirrhosis:: a prospective study on the incidence and hierarchy of major complications [J].
Benvegnù, L ;
Gios, M ;
Boccato, S ;
Alberti, A .
GUT, 2004, 53 (05) :744-749
[2]   Obesity Is an Independent Risk Factor for Clinical Decompensation in Patients with Cirrhosis [J].
Berzigotti, Annalisa ;
Garcia-Tsao, Guadalupe ;
Bosch, Jaime ;
Grace, Norman D. ;
Burroughs, Andrew K. ;
Morillas, Rosa ;
Escorsell, Angels ;
Carlos Garcia-Pagan, Juan ;
Patch, David ;
Matloff, Daniel S. ;
Groszmann, Roberto J. .
HEPATOLOGY, 2011, 54 (02) :555-561
[3]   Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis [J].
Bhanji, Rahima A. ;
Moctezuma-Velazquez, Carlos ;
Duarte-Rojo, Andres ;
Ebadi, Maryam ;
Ghosh, Sunita ;
Rose, Christopher ;
Montano-Loza, Aldo J. .
HEPATOLOGY INTERNATIONAL, 2018, 12 (04) :377-386
[4]   Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis [J].
Cacciola, Irene ;
Filomia, Roberto ;
Alibrandi, Angela ;
Franze, Maria Stella ;
Caccamo, Gaia ;
Maimone, Sergio ;
Saitta, Carlo ;
Saffioti, Francesca ;
Squadrito, Giovanni ;
Raimondo, Giovanni .
LIVER INTERNATIONAL, 2018, 38 (07) :1220-1229
[5]   Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up [J].
Desiderio, Jacopo ;
Trastulli, Stefano ;
Pasquale, Rosario ;
Cavaliere, Davide ;
Cirocchi, Roberto ;
Boselli, Carlo ;
Noya, Giuseppe ;
Parisi, Amilcare .
LANGENBECKS ARCHIVES OF SURGERY, 2013, 398 (01) :55-62
[6]   High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity [J].
Donato, MF ;
Arosio, E ;
Del Ninno, E ;
Ronchi, G ;
Lampertico, P ;
Morabito, A ;
Balestrieri, MR ;
Colombo, M .
HEPATOLOGY, 2001, 34 (03) :523-528
[7]   Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis [J].
Ebadi, Maryam ;
Tandon, Puneeta ;
Moctezuma-Velazquez, Carlos ;
Ghosh, Sunita ;
Baracos, Vickie E. ;
Mazurak, Vera C. ;
Montano-Loza, Aldo J. .
JOURNAL OF HEPATOLOGY, 2018, 69 (03) :608-616
[8]   Sarcopenia and Mortality after Liver Transplantation [J].
Englesbe, Michael J. ;
Patel, Shaun P. ;
He, Kevin ;
Lynch, Raymond J. ;
Schaubel, Douglas E. ;
Harbaugh, Calista ;
Holcombe, Sven A. ;
Wang, Stewart C. ;
Segev, Dorry L. ;
Sonnenday, Christopher J. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (02) :271-278
[9]  
Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x
[10]   External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy [J].
Gui, Honglian ;
Huang, Yan ;
Zhao, Gangde ;
Chen, Lichang ;
Cai, Wei ;
Wang, Hui ;
Guo, Qing ;
Xie, Qing .
FRONTIERS IN MEDICINE, 2021, 8